Impact of autologous stem cell transplantation on survival outcomes in patients with peripheral T cell lymphoma

被引:1
作者
Guren, Ceren Uzunoglu [1 ,4 ]
Toptas, Tayfur [1 ]
Mehtap, Ozgur [2 ]
Yilmaz, Guven [3 ]
Polat, Gokcen [2 ]
Oruc, Ozen [1 ]
Ercan, Tarik [1 ]
Arikan, Fatma [1 ]
Yilmaz, Fergun [1 ]
Atagunduz, Isik Kaygusuz [1 ]
Tuglular, Tulin [1 ]
机构
[1] Marmara Univ Hosp, Dept Hematol, Istanbul, Turkey
[2] Kocaeli Univ Hosp, Dept Hematol, Kocaeli, Turkey
[3] Lutfi Kirdar Training & Res Hosp, Dept Hematol, Istanbul, Turkey
[4] Univ Hosp, Dept Hematol, Istanbul 34899, Turkey
关键词
Peripheral T cell lymphoma; Autologous stem cell transplantation; Prognosis of peripheral T cell lymphoma; NON-HODGKIN-LYMPHOMA; PROGNOSTIC-FACTORS; CONSOLIDATION; PTCL;
D O I
10.1016/j.transci.2022.103514
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data about the timing of autologous stem cell transplantation (ASCT) in peripheral T cell lymphoma (PTCL) are conflicting. We aimed to investigate the impact of the sequence of ASCT on the survival outcomes in patients with PTCL. Analyzes were performed retrospectively in a total of 81 patients, 16 of whom underwent upfront ASCT and 12 received salvage ASCT. In univariate analysis, upfront ASCT reduced the risk of progression and death by 77% (Hazard ratio (HR): 0.23, 95% confidence interval (CI): 0.09-0.60) (p = 0.003) and by 84% (HR: 0.16, 95% CI: 0.5-0.55) (p = 0.003), respectively. However, in multivariate analysis, only salvage ASCT predicted a more favorable progression-free and overall survival (HR: 0.17, 95% CI: 0.06-0.48, p = 0.001 and HR: 0.20, %95 GA: 0.06-0.62, p = 0.005, respectively). In conclusion, regardless of first-line therapy, patients have more favorable outcomes if they receive salvage ASCT. Upfront ASCT does not add clinically significant benefit to survival outcomes.
引用
收藏
页数:6
相关论文
共 22 条
[1]   Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy [J].
Abramson, J. S. ;
Feldman, T. ;
Kroll-Desrosiers, A. R. ;
Muffly, L. S. ;
Winer, E. ;
Flowers, C. R. ;
Lansigan, F. ;
Nabhan, C. ;
Nastoupil, L. J. ;
Nath, R. ;
Goy, A. ;
Castillo, J. J. ;
Jagadeesh, D. ;
Woda, B. ;
Rosen, S. T. ;
Smith, S. M. ;
Evens, A. M. .
ANNALS OF ONCOLOGY, 2014, 25 (11) :2211-2217
[2]   Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro [J].
d'Amore, F. ;
Gaulard, P. ;
Truemper, L. ;
Corradini, P. ;
Kim, W. -S. ;
Specht, L. ;
Pedersen, M. Bjerregaard ;
Ladetto, M. .
ANNALS OF ONCOLOGY, 2015, 26 :V108-V115
[3]   Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01 [J].
d'Amore, Francesco ;
Relander, Thomas ;
Lauritzsen, Grete F. ;
Jantunen, Esa ;
Hagberg, Hans ;
Anderson, Harald ;
Holte, Harald ;
Osterborg, Anders ;
Merup, Mats ;
Brown, Peter ;
Kuittinen, Outi ;
Erlanson, Martin ;
Ostenstad, Bjorn ;
Fagerli, Unn-Merete ;
Gadeberg, Ole V. ;
Sundstrom, Christer ;
Delabie, Jan ;
Ralfkiaer, Elisabeth ;
Vornanen, Martine ;
Toldbod, Helle E. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3093-3099
[4]   Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis [J].
El-Asmarl, Jessica ;
Reljic, Tea ;
Ayala, Ernesto ;
Hamadani, Mehdi ;
Nishihori, Taiga ;
Kumar, Ambuj ;
Kharfan-Dabaja, Mohamed A. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) :802-814
[5]   Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry [J].
Ellin, Fredrik ;
Landstrom, Jenny ;
Jerkeman, Mats ;
Relander, Thomas .
BLOOD, 2014, 124 (10) :1570-1577
[6]   Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma -: The MD Anderson Cancer Center experience [J].
Escalón, MP ;
Liu, NS ;
Yang, Y ;
Hess, M ;
Smith, TL ;
Dang, NH .
CANCER, 2005, 103 (10) :2091-2098
[7]   Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers [J].
Fossard, G. ;
Broussais, F. ;
Coelho, I. ;
Bailly, S. ;
Nicolas-Virelizier, E. ;
Toussaint, E. ;
Lancesseur, C. ;
Le Bras, F. ;
Willems, E. ;
Tchernonog, E. ;
Chalopin, T. ;
Delarue, R. ;
Gressin, R. ;
Chauchet, A. ;
Gyan, E. ;
Cartron, G. ;
Bonnet, C. ;
Haioun, C. ;
Damaj, G. ;
Gaulard, P. ;
Fornecker, L. ;
Ghesquieres, H. ;
Tournilhac, O. ;
Gomes da Silva, M. ;
Bouabdallah, R. ;
Salles, G. ;
Bachy, E. .
ANNALS OF ONCOLOGY, 2018, 29 (03) :715-723
[8]   Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma [J].
Fuji, Shigeo ;
Kurosawa, Saiko ;
Inamoto, Yoshihiro ;
Murata, Tatsunori ;
Fuji, Takao ;
Kim, Sung-Won ;
Fukuda, Takahiro .
BONE MARROW TRANSPLANTATION, 2019, 54 (02) :304-307
[9]   Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study [J].
Gallamini, A ;
Stelitano, C ;
Calvi, R ;
Bellei, M ;
Mattei, D ;
Vitolo, U ;
Morabito, F ;
Martelli, M ;
Brusamolino, E ;
Iannitto, E ;
Zaja, F ;
Cortelazzo, S ;
Rigacci, L ;
Devizzi, L ;
Todeschini, G ;
Santini, G ;
Brugiatelli, M ;
Federico, M .
BLOOD, 2004, 103 (07) :2474-2479
[10]   T-Cell Lymphomas, Version 1.2021 Featured Updates to the NCCN Guidelines [J].
Horwitz, Steven M. ;
Ansell, Stephen ;
Ai, Weiyun Z. ;
Barnes, Jeffrey ;
Berta, Stefan K. ;
Clemens, Mark W. ;
Dogan, Ahmet ;
Goodman, Aaron M. ;
Goyal, Gaurav ;
Guitart, Joan ;
Halwani, Ahmad ;
Haverkos, Bradley M. ;
Hoppe, Richard T. ;
Jacobsen, Eric ;
Jagadeesh, Deepa ;
Jones, Allison ;
Kim, Youn H. ;
Mehta-Shah, Neha ;
Olsen, Elise A. ;
Pro, Barbara ;
Rajguru, Saurabh A. ;
Rozati, Sima ;
Said, Jonathan ;
Shaver, Aaron ;
Shustov, Andrei ;
Sokol, Lubomir ;
Torka, Pallawi ;
Torres-Cabala, Carlos ;
Wilcox, Ryan ;
William, Basem M. ;
Zain, Jasmine ;
Dwyer, Mary A. ;
Sundar, Hema .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (11) :1461-+